NordicTrip
NBG-19-01; SWEBCG 19-01
A Translational Randomized phase III study
The study is open for recruitment!
Contact the Project coordinators for more information
Aim of the study
The goal of the study is to evaluate the pathologic complete response rate in patients with Triple Negative Breast Cancer receiving preoperative Platinum based Chemotherapy +- Capecitabine.
Collaborators
Representatives from:
SABO/SweBCG Sweden, PI Niklas Loman
DBCG Denmark, PI Bent Ejlertsen
FBCG Finland, PI Minna Tanner
IBCG Iceland, PI Oskar Thor Johannsson
The NordicTrip Studyteam
Contact information
Project coordinator:
Anette Ahlin Gullers: 046-17 76 34
Medical Physician:
Niklas Loman
Laboratory:
Siker Kimbung
